Logo image of EUK.MI

EUKEDOS SPA (EUK.MI) Stock Fundamental Analysis

BIT:EUK - Euronext Milan - IT0004818297 - Common Stock - Currency: EUR

0.805  -0.01 (-0.62%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EUK. EUK was compared to 23 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of EUK while its profitability can be described as average. EUK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

EUK had positive earnings in the past year.
In the past year EUK had a positive cash flow from operations.
EUK had positive earnings in 4 of the past 5 years.
EUK had a positive operating cash flow in each of the past 5 years.
EUK.MI Yearly Net Income VS EBIT VS OCF VS FCFEUK.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

The Return On Assets of EUK (0.39%) is worse than 73.08% of its industry peers.
Looking at the Return On Equity, with a value of 2.41%, EUK is doing worse than 73.08% of the companies in the same industry.
With a Return On Invested Capital value of 2.84%, EUK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for EUK is below the industry average of 5.35%.
The last Return On Invested Capital (2.84%) for EUK is above the 3 year average (2.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.39%
ROE 2.41%
ROIC 2.84%
ROA(3y)0.35%
ROA(5y)0.03%
ROE(3y)1.78%
ROE(5y)0.1%
ROIC(3y)2.59%
ROIC(5y)2.22%
EUK.MI Yearly ROA, ROE, ROICEUK.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 -4 -6

1.3 Margins

EUK's Profit Margin of 1.46% is on the low side compared to the rest of the industry. EUK is outperformed by 61.54% of its industry peers.
EUK's Profit Margin has declined in the last couple of years.
EUK's Operating Margin of 11.42% is amongst the best of the industry. EUK outperforms 88.46% of its industry peers.
In the last couple of years the Operating Margin of EUK has grown nicely.
EUK has a better Gross Margin (94.27%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of EUK has remained more or less at the same level.
Industry RankSector Rank
OM 11.42%
PM (TTM) 1.46%
GM 94.27%
OM growth 3Y55.02%
OM growth 5Y20.93%
PM growth 3YN/A
PM growth 5Y-9.95%
GM growth 3Y1.06%
GM growth 5Y0.2%
EUK.MI Yearly Profit, Operating, Gross MarginsEUK.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

EUK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EUK remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EUK has about the same amount of shares outstanding.
Compared to 1 year ago, EUK has an improved debt to assets ratio.
EUK.MI Yearly Shares OutstandingEUK.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
EUK.MI Yearly Total Debt VS Total AssetsEUK.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 0.32, we must say that EUK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EUK (0.32) is worse than 76.92% of its industry peers.
The Debt to FCF ratio of EUK is 30.81, which is on the high side as it means it would take EUK, 30.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EUK (30.81) is worse than 84.62% of its industry peers.
EUK has a Debt/Equity ratio of 3.18. This is a high value indicating a heavy dependency on external financing.
EUK has a Debt to Equity ratio of 3.18. This is in the lower half of the industry: EUK underperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.18
Debt/FCF 30.81
Altman-Z 0.32
ROIC/WACC0.57
WACC4.99%
EUK.MI Yearly LT Debt VS Equity VS FCFEUK.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.47 indicates that EUK may have some problems paying its short term obligations.
With a Current ratio value of 0.47, EUK is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
EUK has a Quick Ratio of 0.47. This is a bad value and indicates that EUK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EUK (0.43) is worse than 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.43
EUK.MI Yearly Current Assets VS Current LiabilitesEUK.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.98% over the past year.
The earnings per share for EUK have been decreasing by -12.18% on average. This is quite bad
The Revenue has been growing slightly by 5.09% in the past year.
EUK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.72% yearly.
EPS 1Y (TTM)75.98%
EPS 3YN/A
EPS 5Y-12.18%
EPS Q2Q%55.04%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.37%
Revenue growth 5Y-1.72%
Sales Q2Q%7.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EUK.MI Yearly Revenue VS EstimatesEUK.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
EUK.MI Yearly EPS VS EstimatesEUK.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.01 0.02 0.03 0.04 0.05

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EUK is valuated quite expensively with a Price/Earnings ratio of 26.83.
Compared to the rest of the industry, the Price/Earnings ratio of EUK indicates a slightly more expensive valuation: EUK is more expensive than 65.38% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of EUK to the average of the S&P500 Index (29.35), we can say EUK is valued inline with the index average.
Industry RankSector Rank
PE 26.83
Fwd PE N/A
EUK.MI Price Earnings VS Forward Price EarningsEUK.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

EUK's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, EUK is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.36
EV/EBITDA 9.23
EUK.MI Per share dataEUK.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EUK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUKEDOS SPA

BIT:EUK (3/5/2025, 7:00:00 PM)

0.805

-0.01 (-0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.62%
Ins Owner ChangeN/A
Market Cap18.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.83
Fwd PE N/A
P/S 0.37
P/FCF 5.36
P/OCF 1.67
P/B 0.62
P/tB 1.92
EV/EBITDA 9.23
EPS(TTM)0.03
EY3.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY18.64%
OCF(TTM)0.48
OCFY59.85%
SpS2.15
BVpS1.31
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.39%
ROE 2.41%
ROCE 3.78%
ROIC 2.84%
ROICexc 2.93%
ROICexgc 3.42%
OM 11.42%
PM (TTM) 1.46%
GM 94.27%
FCFM 6.97%
ROA(3y)0.35%
ROA(5y)0.03%
ROE(3y)1.78%
ROE(5y)0.1%
ROIC(3y)2.59%
ROIC(5y)2.22%
ROICexc(3y)2.68%
ROICexc(5y)2.29%
ROICexgc(3y)3.13%
ROICexgc(5y)2.67%
ROCE(3y)3.45%
ROCE(5y)2.96%
ROICexcg growth 3Y54.39%
ROICexcg growth 5Y-11.72%
ROICexc growth 3Y54.75%
ROICexc growth 5Y-4.64%
OM growth 3Y55.02%
OM growth 5Y20.93%
PM growth 3YN/A
PM growth 5Y-9.95%
GM growth 3Y1.06%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 3.18
Debt/FCF 30.81
Debt/EBITDA 7.36
Cap/Depr 103.84%
Cap/Sales 15.41%
Interest Coverage 250
Cash Conversion 85.23%
Profit Quality 476.01%
Current Ratio 0.47
Quick Ratio 0.43
Altman-Z 0.32
F-Score7
WACC4.99%
ROIC/WACC0.57
Cap/Depr(3y)53.48%
Cap/Depr(5y)58.36%
Cap/Sales(3y)7.91%
Cap/Sales(5y)8.13%
Profit Quality(3y)602.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.98%
EPS 3YN/A
EPS 5Y-12.18%
EPS Q2Q%55.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.37%
Revenue growth 5Y-1.72%
Sales Q2Q%7.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.88%
EBIT growth 3Y57.15%
EBIT growth 5Y18.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.72%
FCF growth 3Y41.34%
FCF growth 5Y6.09%
OCF growth 1Y87.38%
OCF growth 3Y14.71%
OCF growth 5Y14.79%